 The purpose of this study is to evaluate the pharmacokinetics PK, safety and tolerability of a single oral dose of LEE011 in subjects with varying degrees of impaired hepatic function based on Child-Pugh classification as compared to demographically-matched control subjects with normal hepatic function. 